Cargando…

Impact of High-Density Lipoproteins on Sepsis

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Here, we review the impact of high-density lipoproteins (HDL) on sepsis from the perspective of biochemistry and pathophysiology, epidemiological research, and intervention studies in animals. Pathoge...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Geest, Bart, Mishra, Mudit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655469/ https://www.ncbi.nlm.nih.gov/pubmed/36361756 http://dx.doi.org/10.3390/ijms232112965

Ejemplares similares

High-Density Lipoprotein-Targeted Therapies for Heart Failure
por: Mishra, Mudit, et al.
Publicado: (2020)

New Perspectives on Cholesterol and Lipoprotein Metabolism
por: De Geest, Bart, et al.
Publicado: (2023)

Impact of Sepsis on High-Density Lipoprotein Metabolism
por: Reisinger, Alexander C., et al.
Publicado: (2022)

Increased Remnant Lipoproteins in Apo E Deficient Mice Induce Coronary Atherosclerosis following Transverse Aortic Constriction and Aggravate the Development of Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure
por: Muthuramu, Ilayaraja, et al.
Publicado: (2022)

Role of Oxidative Stress in Diabetic Cardiomyopathy
por: De Geest, Bart, et al.
Publicado: (2022)

Role of Oxidative Stress in Heart Failure: Insights from Gene Transfer Studies
por: De Geest, Bart, et al.
Publicado: (2021)

High-density lipoproteins during sepsis: from bench to bedside
por: Tanaka, Sébastien, et al.
Publicado: (2020)

The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure Management: The Continuing Challenge of Clinical Outcome Endpoints in Heart Failure Trials
por: Ji, Luxi, et al.
Publicado: (2023)

HDL dysfunction, function, and heart failure
por: Mishra, Mudit, et al.
Publicado: (2019)

High-Density Lipoproteins and the Kidney
por: Strazzella, Arianna, et al.
Publicado: (2021)

High Density Lipoproteins and Diabetes
por: Cochran, Blake J., et al.
Publicado: (2021)

High-Density Lipoproteins Are Bug Scavengers
por: Meilhac, Olivier, et al.
Publicado: (2020)

High-Density Lipoproteins in Kidney Disease
por: Kon, Valentina, et al.
Publicado: (2021)

Administration of apo A-I (Milano) nanoparticles reverses pathological remodelling, cardiac dysfunction, and heart failure in a murine model of HFpEF associated with hypertension
por: Mishra, Mudit, et al.
Publicado: (2020)

Structure and Dynamics of Oxidized Lipoproteins In Vivo: Roles of High-Density Lipoprotein
por: Itabe, Hiroyuki, et al.
Publicado: (2021)

Low lymphocyte to high-density lipoprotein ratio predicts mortality in sepsis patients
por: Liu, Wanjun, et al.
Publicado: (2023)

High-Density Lipoproteins and the Immune System
por: Kaji, Hidesuke
Publicado: (2013)

High-density lipoprotein cholesterol: How High
por: Rajagopal, G., et al.
Publicado: (2012)

Cholesterol-Lowering Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic Mice
por: Aboumsallem, Joseph Pierre, et al.
Publicado: (2019)

Nanobiotechnology applications of reconstituted high density lipoprotein
por: Ryan, Robert O
Publicado: (2010)

High density lipoproteins and atherosclerosis: emerging aspects
por: Sala, Federica, et al.
Publicado: (2012)

Proprotein convertases in high-density lipoprotein metabolism
por: Choi, Seungbum, et al.
Publicado: (2013)

High density lipoprotein mimicking nanoparticles for atherosclerosis
por: Chen, Jun, et al.
Publicado: (2020)

The Impact of Lipoprotein Apheresis on Oxidative Stress Biomarkers and High-Density Lipoprotein Subfractions
por: Mickiewicz, Agnieszka, et al.
Publicado: (2020)

The Role of High Density Lipoproteins in Thrombosis
por: Cuchel, Marina, et al.
Publicado: (2002)

The Levels of Oxidized Phospholipids in High-Density Lipoprotein During the Course of Sepsis and Their Prognostic Value
por: Li, Zhaohong, et al.
Publicado: (2022)

The relationship between high density lipoprotein cholesterol and sepsis: A clinical and genetic approach
por: Liu, Ge, et al.
Publicado: (2023)

High-Density Lipoprotein and Prostate Cancer: An Overview
Publicado: (2013)

High-Density Lipoproteins and Mediterranean Diet: A Systematic Review
por: Grao-Cruces, Elena, et al.
Publicado: (2021)

High-Density Lipoproteins: A Role in Inflammation in COPD
por: Kotlyarov, Stanislav
Publicado: (2022)

Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research
por: Kornmueller, Karin, et al.
Publicado: (2019)

The Alcohol–High-Density Lipoprotein Athero-Protective Axis
por: Rosales, Corina, et al.
Publicado: (2020)

High-Density Lipoproteins as Homeostatic Nanoparticles of Blood Plasma
por: Kudinov, Vasily A., et al.
Publicado: (2020)

Revealing the Role of High-Density Lipoprotein in Colorectal Cancer
por: Zeljkovic, Aleksandra, et al.
Publicado: (2021)

High density lipoproteins and oxidative stress in breast cancer
por: Mazzuferi, Gabriele, et al.
Publicado: (2021)

Current Understanding of the Immunomodulatory Activities of High-Density Lipoproteins
por: Trakaki, Athina, et al.
Publicado: (2021)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy
por: Lin, Yun, et al.
Publicado: (2010)

Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?
por: Nurmohamed, Nick S, et al.
Publicado: (2021)

Reconstituted HDL (Milano) Treatment Efficaciously Reverses Heart Failure with Preserved Ejection Fraction in Mice
por: Mishra, Mudit, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ur6va11g1j7bkq21q07mbdoe5o